Clarity Medical Group Holding Limited (HKG:1406)
Hong Kong · Delayed Price · Currency is HKD 0.3550
+0.0200 (5.97%)
Apr 14, 2025, 9:50 AM HKT
HKG:1406 Ratios and Metrics
Market cap in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 11, 2025 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 188 | 190 | 204 | 359 | 496 | 637 | |
Market Cap Growth | -37.63% | -6.50% | -43.30% | -27.66% | -22.08% | - |
Enterprise Value | 84 | 87 | 100 | 227 | 300 | 575 |
Last Close Price | 0.35 | 0.35 | 0.39 | 0.68 | 0.94 | 1.25 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 11, 2025 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | - | - | - | - | - | 47.23 |
PS Ratio | 1.06 | 1.07 | 1.13 | 1.88 | 2.32 | 2.83 |
PB Ratio | 1.60 | 1.62 | 1.26 | 1.90 | 1.92 | 2.49 |
P/TBV Ratio | 1.60 | 1.62 | 1.26 | 1.90 | 1.92 | 2.49 |
P/FCF Ratio | - | - | 19.69 | - | - | 23.30 |
P/OCF Ratio | - | - | 11.39 | - | 30.60 | 23.13 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 11, 2025 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 0.47 | 0.49 | 0.55 | 1.19 | 1.40 | 2.55 |
EV/EBITDA Ratio | - | - | - | - | - | 13.31 |
EV/EBIT Ratio | - | - | - | - | - | 16.20 |
EV/FCF Ratio | - | - | 9.66 | - | - | 21.02 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 11, 2025 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.24 | 0.24 | 0.06 | 0.13 | 0.18 | 0.08 |
Debt / EBITDA Ratio | - | - | - | - | 2.75 | 0.35 |
Debt / FCF Ratio | - | - | 0.96 | - | - | 0.74 |
Net Debt / Equity Ratio | -0.55 | -0.55 | -0.76 | -0.61 | -0.62 | -0.87 |
Net Debt / EBITDA Ratio | 1.64 | 1.64 | 5.35 | 2.88 | 103.85 | -5.12 |
Net Debt / FCF Ratio | 2.23 | 2.23 | -11.86 | 2.40 | 11.46 | -8.09 |
Asset Turnover | 0.96 | 0.96 | 0.83 | 0.68 | 0.69 | 1.11 |
Inventory Turnover | 38.25 | 38.25 | 29.81 | 27.91 | 25.06 | 20.90 |
Quick Ratio | 3.16 | 3.16 | 3.93 | 3.80 | 5.24 | 10.06 |
Current Ratio | 3.26 | 3.26 | 4.10 | 4.41 | 5.81 | 10.32 |
Return on Equity (ROE) | -33.30% | -33.30% | -19.55% | -33.77% | -1.24% | 8.03% |
Return on Assets (ROA) | -16.65% | -16.65% | -9.62% | -12.47% | -1.56% | 10.89% |
Return on Invested Capital (ROIC) | -93.36% | -107.80% | -59.83% | -65.18% | -11.58% | 81.16% |
Return on Capital Employed (ROCE) | -35.50% | -35.50% | -20.40% | -28.40% | -2.70% | 13.30% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 11, 2025 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | -24.72% | -24.38% | -16.84% | -21.11% | -0.64% | 2.12% |
FCF Yield | -15.47% | -15.26% | 5.08% | -13.48% | -2.82% | 4.29% |
Payout Ratio | - | - | - | - | - | 192.72% |
Buyback Yield / Dilution | -1.40% | -1.40% | -0.15% | -1.09% | -33.76% | -4.15% |